Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the cell therapy technologies market right now?

The market size for cell therapy technologies has seen a swift expansion in the recent years. The market, which sized at $4.92 billion in 2024, is predicted to increase to $5.67 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 15.4%. The rise in the past period is due to robust economic development in emerging markets, heightened healthcare spending, augmented government-directed investment in cell-based research, and an escalating demand for personalized medicine.

How fast Is the cell therapy technologies market expected to grow, and what’s its future value?

The market size for cell therapy technologies is set to experience considerable expansion in the coming years, projecting a growth to $9.87 billion in 2029 with a 14.9% compound annual growth rate (CAGR). This predicted increase during the forecast period can be related to the growing elderly population, the rising occurrence of cancer, an escalating investment in research and development within the pharmaceutical industry, and progress in cell therapies. Significant trends expected during the forecast period include innovation in product development, adoption of cutting-edge technology, novelty in cell therapies, investments in production facilities, as well as strategic partnerships and collaborations.

Get your cell therapy technologies market report here!

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

What are the leading drivers of growth in the cell therapy technologies market?

The global cell therapy technologies market is experiencing growth, largely due to a surge in government funding for cell-based studies. Governments are stepping up their investment in research initiatives aimed at developing treatments for diseases like cancer and cardiovascular disease (CVD), among others. Case in point, in May 2022, The California Institute for Regenerative Medicine (CIRM), a research institute committed to aiding stem cell research, devoted over $11 million to support a clinical trial of cell therapy to treat throat cancer. The successful completion of this therapy has the potential to eliminate the need for patients to undergo radiotherapy, thus sparing them from its associated side effects.

What are the key segments defining the cell therapy technologies market?

The cell therapy technologies market covered in this report is segmented –

1) By Product: Consumables, Equipment, Systems And Software

2) By Cell Type: T-Cells, Stem Cells, Other Cells

3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control

4) By End User: Life Science Companies, Research Institutes And Cell Banks

Subsegments:

1) By Consumables: Cell Culture Media, Bioreactors And Cell Culture Vessels, Cell Separation And Processing Kits, Cryopreservation Bags And Vials

2) By Equipment: Cell Counters, Centrifuges, Cell Sorting Equipment, Incubators

3) By Systems And Software: Closed-System Cell Processing Systems, Automated Cell Culture Systems, Point-Of-Care Cell Therapy Systems, Laboratory Information Management Systems (LIMS), Data Management Software For Cell Therapies, Process Optimization And Tracking Software

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

Who are the key players steering the development of the cell therapy technologies market?

Major companies operating in the cell therapy technologies market include Lonza Group AG, Thermo Fisher Scientific Inc, Merck KGaA, Terumo Corporation, Danaher Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Holdings Corporation, Sartorius AG, Becton Dickinson and Company, Avantor Inc., Cellular Biomedicine Group, CORESTEM, Astellas Pharma Inc, Anterogen Co. Ltd, Arce Therapeutics, CARsgen Therapeutics, Huadong Medicine, Co.Don AG, AstraZeneca, Neogene Therapeutics, GammaDelta Therapeutics Limited, Nightstar, SOTIO, Accell Clinical Research, Genestack, Novartis AG, Pfizer, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Bayer AG, Gilead Sciences, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Amgen, Regen BioPharma, Bellicum, Amgen Brazil, GlaxoSmithKline plc, Biogen Brazil, Takeda Pharmaceutical Company Limited, Pfizer S.R.L, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Bayer East Africa Ltd, Adcock Ingram, Next BioSciences, CryoSave, BioHeart, Stem Cell Technologies.

What emerging trends are influencing the growth of the cell therapy technologies market?

Significant corporations in the cell therapy technologies market are striving for growth by inventing novel products through advanced technological approaches. In June 2022, for example, Invetech, a company based in Australia that focuses on designing, engineering, and producing large-scale diagnostic products as well as cell and gene therapies, introduced Korus. This novel autologous cell therapy closed system aims to revolutionize industry norms in cell wash and elutriation. This technology employs a gentle elutriation procedure to provide a filtered cell population for the production processes of cell therapy, such as dendritic cells, tumor-infiltrated lymphocytes (TIL), CAR-T cell, or therapy derived from IPSC. It offers cell wash and elutriation using gentle counterflow centrifugation, and delivers refined cell populations for downstream processing development and commercial production. This is expected to enhance overall process performance through increased recovery and purity of the target cells. With the new Korus system, developers can speed up the clinical development and scaling of their products.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4122

Which regions are most influential in expanding the cell therapy technologies market?

North America was the largest region in the cell therapy technologies market in 2024. Asia-Pacific is predicted to record the fastest growth over the forecast period. The regions covered in the cell therapy technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cellular Telephones Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cellular-telephone-global-market-report

Cell Based Assays Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Cell Culture Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: